OTC Markets EXMKT - Delayed Quote USD

Medical International Technology, Inc. (MDLH)

Compare
0.0001
+0.0001
(0.00%)
As of April 4 at 4:00:00 PM EDT. Market Open.
Loading Chart for MDLH
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0001
  • Volume 10,000
  • Avg. Volume 345
  • Market Cap (intraday) 185,470
  • Beta (5Y Monthly) -15.70
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Medical International Technology, Inc. produces, markets, and sells needle-free jet injector products for use in humans and animals. It offers Med-Jet model needle-free injection systems for medical, cosmetic dermatology, and mesotherapy applications, as well as for single and mass vaccination in humans; Agro-Jet and Avian-Jet needle-free injection systems for small farm animal, pets clinic use, and livestock vaccination; Avian-Jet needle-free injectors for poultry vaccination; and MINI-JET for day old chick vaccination. The company sells its products to doctors, dentists, nurses, veterinarians, farmers, and home users in approximately 30 countries, including the United States. Medical International Technology, Inc. is based in Montreal, Canada.

www.mitcanada.ca

3

Full Time Employees

September 30

Fiscal Year Ends

Recent News: MDLH

View More

Performance Overview: MDLH

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MDLH
0.00%
S&P 500 (^GSPC)
14.22%

1-Year Return

MDLH
0.00%
S&P 500 (^GSPC)
3.06%

3-Year Return

MDLH
96.77%
S&P 500 (^GSPC)
12.11%

5-Year Return

MDLH
96.30%
S&P 500 (^GSPC)
89.70%

Compare To: MDLH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MDLH

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -103.00%

  • Return on Assets (ttm)

    -35.53%

  • Return on Equity (ttm)

    -285.20%

  • Revenue (ttm)

    397.69k

  • Net Income Avi to Common (ttm)

    -409.64k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    399.18k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -185.1k

Research Analysis: MDLH

View More

Company Insights: MDLH

Research Reports: MDLH

View More

People Also Watch